SCR-LIP-000101 · Claim · machine-readable JSON →
Multi-omics analysis of lipedema tissue revealed local downregulation of inflammation-related factors alongside upregulation of mitochondrial and oxidative phosphorylation pathways, with minimal systemic inflammatory changes but altered sphingolipid, glutamic acid, and glutathione levels suggesting metabolic rather than classical inflammatory mechanisms.
Claim at a glance
- Type
- clinical association
- Knowledge state
- Emerging
- Evidence certainty
- low (GRADE)
- Evidence
- 1 source(s)
- Answers
- 1 question(s)
- Dates
- 2026-05-31 → 2026-05-31
Structured evidence, machine-compiled — not a verdict.
Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-sonnet-4.6 · 2026-05-31
Evidence over time
Evidence (1)
- Defining lipedema's molecular hallmarks by multi-omics approach for disease prediction in women — Straub et al. (2025) ✓ verified — refining · cross sectional · 2025 · reading confidence: high
“convergência das vias UPREGULADAS ('cellular respiration', 'oxidative phosphorylation', 'mitochondrial organization') e das DOWNREGULADAS ('immune effector process', 'leukocyte mediated immunity', 'innate immune response', 'inflammatory response')”
The study directly investigates molecular mechanisms in lipedema tissue using transcriptomics, proteomics, metabolomics, and lipidomics, providing specific findings about inflammation pathways; however, it is cross-sectional and observation
Context (PECO)
Answers these questions
Gaps & caveats
Auto-ingested single source; not yet human-reviewed.
Change log
- 2026-05-31 — created